Merck Research Laboratories articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/09/18 10:08
2014/09/18 10:08
1d
MSD, known as Merck & Co., Inc. (NYSE: MRK) in the United States and Canada, today announced the presentation of the first data from the Phase 3 clinical development programme for omarigliptin, MSD’s...
2014/09/18 10:08
2014/09/18 10:08
Latest videos
2014/09/17 15:14
2014/09/17 15:14
2d
Sun Pharmaceutical Industries Ltd. has acquired the worldwide rights to Merck & Co., Inc.'s psoriasis drug tildrakizumab for $80 million, the two companies announced Wednesday. Sun Pharma, based in...
2014/09/14 15:34
2014/09/14 15:34
5d
Solana Beach resident heads Parkinson’s Institute and Clinical Center Carrolee Barlow Photo by AmyAnne Photography When Carrolee Barlow was appointed CEO of an organization that researches and...
2014/09/08 21:17
2014/09/08 21:17
11d
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, chairman and chief executive officer; Adam H....
2014/09/04 13:17
2014/09/04 13:17
15d
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated...
2014/08/26 17:14
2014/08/26 17:14
24d
Princeton-based biotechnology company Advaxis, Inc., announced Monday that it has joined with Merck on a clinical trial collaboration agreement that will study a combination of an Advaxis cancer...
Read more at NJ Biz, Business Wire
2014/08/15 05:08
2014/08/15 05:08
m
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved BELSOMRA® (suvorexant) for adults with insomnia who...
2014/09/18 10:08
2014/09/18 10:08
Latest from Twitter